Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

95.62 +2.25 (+2.40%)
Streaming Delayed Price Updated: 1:15 PM EDT, May 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about TransMedics Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
3 Mid-Cap Medical Stocks Outperforming the Market
Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness. 
Via MarketBeat
Topics Economy
Exposures Economy
1 Beaten-Down Stock to Buy Right Now and Hold for a Decade
Via The Motley Fool
Topics Government World Trade
Exposures Political Tariff
P/E Ratio Insights for TransMedics Group
Via Benzinga
Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock
Via Benzinga
Down 62%. Should You Buy TransMedics Stock on the Dip?
Via The Motley Fool
Is the Market Bullish or Bearish on TransMedics Gr?
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
The Analyst Verdict: TransMedics Gr In The Eyes Of 8 Experts
Via Benzinga
TransMedics Group Stock: A Millionaire-Maker in the Making?
Via The Motley Fool
1 Compelling Reason to Buy and Hold TransMedics Group Stock Forever
Via The Motley Fool
1 Turnaround Growth Stock Down 60% That Could Double, According to Wall Street
Via The Motley Fool
TransMedics' Revenue Surged 49.8% in Q4
The organ transplant technology specialist significantly exceeded Wall Street's estimates in the fourth quarter. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Looking At TransMedics Gr's Recent Unusual Options Activity
Via Benzinga
Why TransMedics Fell 15.7% This Week
Via The Motley Fool
Here's How Much You Would Have Made Owning TransMedics Gr Stock In The Last 5 Years
Via Benzinga
Short Seller Accuses TransMedics Of 'Mafia Style' Scheme, Organ Transplant Company Says Short Seller Manipulating Market
TransMedics faces allegations from Scorpion Capital of fraud and organ trafficking, while the company rebuffs the claims as baseless market manipulation. 
Via Benzinga
Topics Fraud
Exposures Legal
TransMedics Stock Is Worth $0 According to This Short-Seller. Here's Why I'm Not Selling.
Via The Motley Fool
Why TransMedics Group Stock Is Tanking Today
Via The Motley Fool
2 MedTech Stocks That Are Screaming Buys in January
Via The Motley Fool
How Is The Market Feeling About TransMedics Gr?
Via Benzinga
Why Transmedics Plunged in December
Via The Motley Fool
1 Super Growth Stock Down 63% to Buy Hand Over Fist in 2025
Via The Motley Fool
Here's How Much You Would Have Made Owning TransMedics Gr Stock In The Last 5 Years
Via Benzinga
Looking Into TransMedics Gr's Recent Short Interest
Via Benzinga
Maximizing Gains: StoryTrading’s Four Pillars Highlight The Best Plays Today
The market kicked off with a notable rally, marking the return of what appears to be a 
Via Talk Markets
Topics Stocks / Equities
"Rule Breaker Investing" Mailbag: Portfolio-Level Thinking
From a preschool teacher newly inspired to invest at 73 to a lifelong Fool whose Microsoft shares became a 500-bagger, this year-end mailbag edition brims with transformational stories. 
Via The Motley Fool
StoryTrading's Secrets To January Gains - Don’t Miss These Picks
As we usher in the new year, market dynamics continue to be shaped by a blend of tax-deferral selling, the January effect, and macro uncertainties. 
Via Talk Markets
Topics Stocks / Equities
10 Overlooked Stocks Set to Soar in 2025
All 10 underperformed in 2024, but I believe they'll turn things around in 2025. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.